Publicacións en colaboración con investigadores/as de Hospital Vall d'Hebron (19)

2024

  1. Microscopic Colitis and Celiac Disease: Sharing More than a Diagnostic Overlap

    Nutrients, Vol. 16, Núm. 14

2023

  1. Genome-wide multi-trait analysis of irritable bowel syndrome and related mental conditions identifies 38 new independent variants

    Journal of Translational Medicine, Vol. 21, Núm. 1

  2. Increased gut permeability and bacterial translocation are associated with fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome: implications for disease-related biomarker discovery

    Frontiers in Immunology, Vol. 14

2022

  1. Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations

    Cells, Vol. 11, Núm. 13

2021

  1. Present and Future Therapeutic Approaches to Barrier Dysfunction

    Frontiers in Nutrition, Vol. 8

2020

  1. Overexpression of corticotropin-releasing factor in intestinal mucosal eosinophils is associated with clinical severity in Diarrhea-Predominant Irritable Bowel Syndrome

    Scientific Reports, Vol. 10, Núm. 1

  2. Peripheral Corticotropin-Releasing Factor Triggers Jejunal Mast Cell Activation and Abdominal Pain in Patients With Diarrhea-Predominant Irritable Bowel Syndrome

    The American journal of gastroenterology, Vol. 115, Núm. 12, pp. 2047-2059

2019

  1. Intestinal mucosal mast cells: Key modulators of barrier function and homeostasis

    Cells, Vol. 8, Núm. 2

2018

  1. Epithelial immunity: Priming defensive responses in the intestinal mucosa

    American Journal of Physiology - Gastrointestinal and Liver Physiology

2017

  1. Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot study

    United European Gastroenterology Journal, Vol. 5, Núm. 6, pp. 887-897

  2. MiR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea

    Gut, Vol. 66, Núm. 9, pp. 1597-1610

2016

  1. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease

    Gut, Vol. 65, Núm. 5, pp. 830-839

2015

  1. Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations

    Gut, Vol. 64, Núm. 9, pp. 1379-1388

2012

  1. Chronic psychosocial stress induces reversible mitochondrial damage and corticotropin-releasing factor receptor type-1 upregulation in the rat intestine and IBS-like gut dysfunction

    Psychoneuroendocrinology, Vol. 37, Núm. 1, pp. 65-77

  2. Gene expression dynamics after murine pancreatitis unveils novel roles for Hnf1α in acinar cell homeostasis

    Gut, Vol. 61, Núm. 8, pp. 1187-1196

  3. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations

    American Journal of Gastroenterology, Vol. 107, Núm. 5, pp. 736-746

2011

  1. Assessment of the protective effects of oral tocotrienols in arginine chronic-like pancreatitis

    American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 301, Núm. 5

2010

  1. Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress

    Brain, Behavior, and Immunity, Vol. 24, Núm. 7, pp. 1166-1175

2009

  1. The epigenetic regulators Bmi1 and Ring1B are differentially regulated in pancreatitis and pancreatic ductal adenocarcinoma

    Journal of Pathology, Vol. 219, Núm. 2, pp. 205-213